VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

VistaGen Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash & Equivalents
48.98M 67.13M 74.72M 84.25M 102.92M 119.17M 126.56M 37.61M 9.62M 16.64M 25.04M 35.29M 51.99M 68.14M 83.7M 93.63M 97.78M 103.11M 104.33M 15.4M 1.55M
Short-Term Investments
14.2M 13.35M 13.85M 13.33M 5.45M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
472K 454K 477K 498K 518K 800K 575.3K 630.3K 823.9K 814.2K 746.5K 763.4K 599.4K 569.1K 556.2K 536.6K 473.3K 576.8K 581.3K 638K 311.7K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a 659K n/a 154.1K 154.1K 681.8K 337.9K n/a n/a 44K 40.6K n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a -591.9K -869.73M 682.1K 1.36M 116.9K 2.45M n/a n/a 1.97M 942.2K n/a n/a n/a
Other Current Assets
3.54M 1.59M 1.38M 2.37M 2.47M 1.43M 74.5K 74.5K 253.5K 67K 96.9K 179.4K 2.33M 2.33M 2.82M 2.45M 169.1K 159.9K 500K 294.8K 1.6K
Total Current Assets
66.72M 82.08M 89.94M 99.95M 110.84M 120.6M 128.11M 39.08M 11.58M 17.51M 26.06M 36.91M 54.99M 71M 86.77M 96.44M 99.83M 104.12M 105M 15.97M 2.18M
Property-Plant & Equipment
1.74M 1.81M 1.89M 2.05M 2.19M 2.25M 2.38M 2.49M 2.63M 2.77M 2.9M 3.02M 3.13M 3.08M 3.21M 3.53M 3.61M 3.59M 3.69M 3.66M 3.68M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
2.21M 2.27M 2.37M 2.55M 2.71M 3.06M 2.95M 3.12M 3.45M 3.58M 3.65M 3.79M 3.73M 3.65M 3.77M 4.06M 4.08M 4.16M 4.28M 4.3M 3.99M
Total Assets
68.92M 84.34M 92.31M 102.5M 113.55M 123.65M 131.07M 42.2M 15.03M 21.09M 29.71M 40.7M 58.73M 74.64M 90.54M 100.5M 103.91M 108.28M 109.27M 20.27M 6.17M
Account Payables
486K 653K 1.04M 715K 1.21M 1.55M 1.74M 1.3M 1.62M 2.47M 1.6M 2.96M 5.47M 2.76M 1.95M 2.66M 2.32M 838.3K 776.4K 1.18M 1.31M
Deferred Revenue
2.51M 2.59M 2.51M 2.47M 2.3M 791K 1.76M 793K 714.3K 714.3K 712.3K 712.3K 1.24M 1.24M 1.42M 1.42M 1.42M 1.42M 1.24M 1.24M n/a
Short-Term Debt
933K 561K 603K 525K 567K 550K 535.4K 518.9K 784.2K 105K 419.1K 730K 1.04M n/a n/a n/a n/a n/a 98.4K 352.6K 428.9K
Other Current Liabilities
6.58M 2.8M -603K -525K -567K 1.07M -535.4K -518.9K 407.4K 707.4K 776.4K 877.4K 486.6K 1.26M 477.5K 1.44M 1.4M n/a n/a n/a n/a
Total Current Liabilities
11.15M 12.61M 9.62M 7.52M 6.24M 5.12M 4.16M 2.91M 4.05M 4.57M 4.29M 6.05M 8.93M 5.77M 6.42M 7.91M 6.27M 4.19M 2.98M 3.3M 2.67M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.13B n/a n/a n/a n/a n/a n/a n/a n/a n/a 87.3K 124.7K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 2.67M n/a n/a n/a -2.13B n/a n/a n/a n/a n/a 7.01M 6.63M 6.27M 5.92M 5.69M 5.35M
Total Long-Term Liabilities
1M 1.34M 1.56M 2M 2.51M 4.24M 3.62M 3.64M 4.13M 4.44M 4.75M 5.05M 3.75M 4.16M 4.14M 11.93M 12.02M 12.11M 12.48M 12.75M 9.11M
Total Liabilities
12.16M 13.95M 11.19M 9.52M 8.74M 9.37M 7.78M 6.55M 8.18M 9.01M 9.03M 11.1M 12.67M 9.93M 10.56M 19.84M 18.29M 16.3M 15.46M 16.05M 11.78M
Total Debt
2.36M 1.51M 1.71M 1.79M 1.99M 2.12M 2.25M 2.38M 3.28M 2.72M 3.15M 3.57M 3.98M 3.04M 3.14M 3.54M 3.63M 3.72M 3.9M 4.32M 4.52M
Common Stock
29K 29K 28K 27K 27K 27K 27K 12K 7.9K 7.3K 207.1K 207K 206.9K 206.7K 206.6K 196.5K 191.6K 180.8K 138.8K 74.1K 55.9K
Retained Earnings
-422.73M -407.63M -394M -379.91M -366.95M -356.21M -346.69M -340.34M -333.75M -326.85M -314.62M -304.86M -287.38M -267.6M -250.92M -240.38M -227.59M -219.84M -213.63M -208.33M -205.03M
Comprehensive Income
1K 5K 11K 22K 2K n/a n/a n/a -0.00 0.00 0.00 0.00 0.00 -0.00 0.00 -3.9K -3.9K -4.3K -5.9K -4K -4K
Shareholders Equity
56.77M 70.39M 81.12M 92.97M 104.8M 114.29M 123.28M 35.65M 6.85M 12.08M 20.67M 29.61M 46.05M 64.72M 79.98M 80.66M 85.62M 91.98M 93.81M 4.22M -5.61M
Total Investments
14.2M 13.35M 13.85M 13.33M 5.45M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a